Skip to main content
Caplight Logo









Avicena Systems

Avicena Systems

Private
PerthHealthcare & Life Scienceshttps://avicenasystems.com/

Last Round

Grant

Feb 13, 2024

Total Funding Raised

$11.06M

Company Overview

Avicena Systems is a biotechnology company that develops and manufactures ultra-high throughput molecular diagnostic and biosecurity screening systems.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Biotechnology, Environmental Monitoring

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Usage-Based SaaS

AI Layer

Non-AI

Keywords

molecular diagnosticspathogen detectionloop-mediated isothermal amplificationLAMPbiosecurityrapid testingpoint-of-care diagnosticsPOC testingmedical devicehigh-throughput screeningbiotech equipmentreagentsconsumablesclinical diagnosticslab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Avicena Systems Comparables

Compare Avicena Systems with similar companies based on industry and business-model similarity.

Avicena Systems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap

View Full Comparables Set

Access detailed peer comparisons, similarity scores, and market data.

Avicena Systems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantFeb 13, 2024
SeedOct 3, 2022
GrantSep 24, 2021
GrantJun 16, 2021
GrantJan 30, 2021
Grant
Oct 1, 2020

Key People

Founding team and executive leadership

Mark Sheridan

Chief Operating Officer

Executive Team

Avicena Systems Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 13, 2024

    Secured $2M from Australian Government and other entities.

  • Oct 3, 2022

    Raised $5.76M in a seed funding round.

Avicena Systems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Avicena Systems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Avicena Systems's valuation, stock price, and market status.

Firmographic Details

HeadquartersPerth
Employee Range12
Year Founded2020
Last FundingFeb 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?